109
Participants
Start Date
October 3, 2014
Primary Completion Date
December 12, 2018
Study Completion Date
December 12, 2018
FluMist® Quadrivalent
LAIV4 vaccine dosage is 0.2 mL. Vaccine will be administered as an intranasal spray. Each sprayer contains a single dose of FluMist® Quadrivalent; approximately one-half of the contents should be administered into each nostril. 0.1 mL (i.e., half of the dose from a single FluMist sprayer) is administered into each nostril while the recipient is in an upright position. Insert the tip of the sprayer just inside the nose and rapidly depress the plunger until the dose-divider clip stops the plunger. The dose divider clip is removed from the sprayer to administer the second half of the dose (0.1 mL) into the other nostril.
Fluzone® Quadrivalent vaccine
IIV4 vaccine will be administered as a 0.5 mL dose, with a sterile, disposable syringe and needle by IM injection into the deltoid muscle.
Stanford University, Stanford
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Stanford University
OTHER